MiniMed Group Q4 2026: Record Sales, 14% Share Rise, and Future Growth
MiniMed Group’s record‑breaking Q4 sales and new glucose‑ketone sensor partnership spark a 14% stock surge, highlighting robust growth and future innovation in diabetes tech.
3 minutes to read